Constituents of priming fluid relative to patient size and priming volume of the oxygenator 1

Limitations and validity of haemodilution. 2

Formulae for calculation of haemodilution. 3

CO2 flushing prior to priming the oxygenator 4

PreCPB filter placement and pore size relative to priming. 4

Inline monitoring of haemodilution. 4

Priming Solutions. 4

 

Constituents of priming fluid relative to patient size and priming volume of the oxygenator

·       Due to benefits of haemodilution and concerns about blood borne diseases, is standard practice to use a nonblood CPB prime

·       Patients < 35 kg may need some blood in prime to avoid excessive haemodilution

·       Haemodilution  [Hct: 21-24%] reduces blood viscosity resulting in:

·       increased tissue perfusion

·       reduced blood cell trauma

·       improved renal function

·       reduced need for homologous blood

 

1.                  Osmolality

a)                  Isosmotic or slightly hypertonic to minimise tissue oedema

b)                  Use of mannitol or albumin

2.                  Electrolytes

a)                  Normal electrolyte balance must be maintained to prevent post CPB electrolyte abnormalities

3.                  Volume

a)                  Enough volume to fill & prime:

i)                    Circuitry, oxygenator, filters, venous reservoir

b)                  Enough volume to enable safe conduct of perfusion:

i)                    venous level, flow rates required

c)                  Not too much volume to cause excessive haemodilution

4.                  Haemodilution

a)                  Avoid < 18 % Hct

b)                  To determine the initial Hct on CPB:

 

Hctint = initial Hct on CPB

EBV = estimated patient blood volume

Hct = preoperative Hct

 

c)                  To determine the volume of red blood cells needed to prime the circuit:

 

PBV = patient’s blood volume

ECCV = extracorporeal circuit volume

CPBHct = desired Hct on CPB

PtHct = patient’s pre CPB Hct

 

Estimate of total blood volume by age

Age

cc/kg

Adult

65

3 years

70

1 year

75

6 months

80

 

 

Acceptable values for prime

pH

7.35-7.45

pO2

80-300 mmHg

pCO2

35-45 mmHg

Na+

< 140 mEq

K+

3.5-5 mEq

Ca2+ (ionised)

approx 1 mmol

Glucose

< 200 mg/dl

Hct

Depends on anticipated degree of hypothermia

Oncotic press

13-16 mmHg

Osmotic press

300 mOsm

 

Avoid SPPS in vacuum primed oxygenators (SciMed)

 

Limitations and validity of haemodilution

1.                  Benefits of haemodilution

a)                  Lowers blood viscosity

i)                    Counteracting sludging effect of hypothermic blood

ii)                  Improves tissue perfusion during hypothermia

b)                  Reduced risks associated with blood transfusions

c)                  See appropriate modules

2.                  Risks of haemodilution

a)                  Reduced MAP upon commencement of CPB

i)                    Due to reduced viscosity

b)                  Lowered colloid osmotic pressure

i)                    Dilution of plasma proteins

ii)                  Require increased I.V. fluid due to 3rd space shifts

c)                  SaO2 must be kept at 100%

i)                    To prevent any decline in O2 transport

ii)                  O2 transport = O2 content ´ blood flow

iii)                 [O2 content = 1.34 ´ Hb ´ SaO2 + dissolved O2]

d)                  Excessive haemodilution

i)                    Blood flow cannot increase to compensate for reduced O2 content

ii)                  Ischaemia of critical organs

iii)                 anaerobic metabolism

e)                  Increased flow

i)                    At similar VO2 (O2 consumption rates), a halving of the Hct requires a doubling of flow

ii)                  Importance of hypothermia to reduce VO2

iii)                 If normothermic, SvO2 may fall on CPB

f)                   Factors reducing ability of body to tolerate significant reductions in Hct:

i)                    Stenosis

a)                  Limits maximum flow of blood

b)                  Reduced viscosity does help however

ii)                  Cardiac failure after CPB

a)                  Unable to maintain sufficient C.O. necessary to maintain adequate O2 delivery

iii)                 Left shifted O2-Hb curve

a)                  Reduces O2 release in tissues

b)                  Hypothermia, alkalosis, reduced 2,3 DPG

iv)                Lung disease

a)                  Unable to maintain sufficient gas exchange necessary to maintain adequate O2 delivery after CPB

g)                  ‘Healthy’ patient

i)                  Able to tolerate down to Hct of 20

 

Formulae for calculation of haemodilution

 

 

 

Hctint = initial Hct on CPB

EBV = estimated patient blood volume

Hct = preoperative Hct

 

Blood volume = Patient weight ´ 8% [infants]

                                    7.5% [child, adult male]

                                    7.0 % [adult female]

 

Red cell volume = Blood volume ´ Hct

 

CO2 flushing prior to priming the oxygenator

·       CO2 purging of the assembled circuitry prior to priming

·       Used to displace atmospheric N2 which is difficult to debubble

·       Occurs for several minutes

·       CO2 is used as has a high water solubility; any CO2 bubbles not washed from the circuit during priming are quickly adsorbed

·       Recirculation of the prime with a O2 gas flow allows for excessive CO2 to be removed from the circuit before commencing CPB

·       The slightly unoccluded pump head will allow the CO2 to permeate the pump boot

 

PreCPB filter placement and pore size relative to priming

·       0.2 microns

·       Upstream of arterial line

·       Removes tubular and oxygenator dust and other debris, microbes and spores, early onset spallation (silastic), particulate matter of what ever source

·      Positioned where all the pump prime will flow, yet is removable prior to commencement of CPB

 

Inline monitoring of haemodilution

Method 1

  1. By using the electrical conductivity of blood, the Hct can be measured with an electrolyte in line analyser

 

Method 2

  1. Hct is measured by using reflected infrared light from formed particles in the blood
  2. The reflected infrared light will be proportional to the percent of red cells in the blood

 

 

Priming Solutions

 

Fluid

grms/l

(ml)

Glu (g)

kJ

Na

K

Cl

Ca

Lactate

pH

Osmolality

0.9% NS

9

1000

154

154

 

 

5% Dextrose

5

1000

50

850

4

278

Hartman’s

 

1000

131

5

112

2

29

5 -7

278

Ringers

 

1000

147

4

156

2.2

 

309?

 

5% DEXTROSE

     Readily available & cheap

     Slightly hypotonic and becomes steadily more so as the dextrose is metabolised leaving the patient with a sizeable water load to excrete

     The marked dilutional effect on plasma bicarbonate produces a marked systemic metabolic acidosis with hyponatraemia & hypochloraemia

     Not recommended for diabetics as may lead to very high glucose levels during CPB

     Due to its effect in raising osmotic pressure in prime, may be associated with reduced postoperative fluid retention & perioperative fluid requirements

     However, CNS damage may occur with hyperglycaemia when associated with global or focal injury is followed by immediate reperfusion of the ischaemic region [therefore should avoid hyperglycaemia particularly in thoracic aortic repairs when are subjecting global CNS ischaemia]

 

HARTMAN’S

     Similar ion concentration to plasma

     Lactate renders Hartman’s slightly acid until liver converts lactate into bicarbonate, eventually producing a metabolic alkalosis

     Diabetic patients are less able to handle the lactate peripherally so that it is more readily converted to glucose thereby exacerbating hyperglycaemia [use of NS or Ringer’s]

     Due to exchange of Na for K in kidneys, may exacerbate hypokalaemia

     Danger of exacerbating any metabolic acidosis by producing lactic acidosis, particularly in seriously ill patients with poor tissue perfusion or impaired hepatic function

 

KCPotger©